Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
3
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Lung Diseases, Interstitial
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Pirfenidone Viatris
Pirfenidone Viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).
View on EMAPirfenidone axunio (previously Pirfenidone AET)
Pirfenidone AET is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).
View on EMAEsbriet
Esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
View on EMA